XML 43 R32.htm IDEA: XBRL DOCUMENT v3.25.2

Equity (Tables)

6 Months Ended

Jun. 30, 2025

Equity (Tables) [Line Items]

Schedule of Stock Option Activity

Stock option activity for the six months ended June 30, 2025 was as follows:

		Number of Options				Weighted Average Exercise Price
Outstanding at January 1, 2025			52,479			$	85.45
Granted			2,665				3.26
Expired / cancelled / forfeited			(10,643	)			(72.85	)
Outstanding at June 30, 2025			44,501			$	83.54
Options exercisable at June 30, 2025			43,171			$	86.01
Options expected to vest			1,330			$	3.26

Schedule of Nonvested Stock Options Granted

A summary of the status of the Company’s nonvested stock options granted as of June 30, 2025 and changes during the six months ended June 30, 2025 is presented below:

		Number of Options				Weighted Average Exercise Price
Nonvested at January 1, 2025			5,943			$	11.54
Granted			2,665				3.26
Cancelled			(1,853	)			(27.40	)
Vested			(5,425	)			(4.08	)
Nonvested at June 30, 2025			1,330			$	3.26

A summary of the status of the Company’s nonvested stock warrants issued as of June 30, 2025 and changes during the six months ended June 30, 2025 is presented below:

		Number of Warrants				Weighted Average Exercise Price
Nonvested at January 1, 2025			80,000			$	7.50
Vested			80,000				7.50
Nonvested at June 30, 2025			-			$	-

Schedule of Stock Warrant Activity

Stock warrant activity for the six months ended June 30, 2025 was as follows:

		Number of Warrants				Weighted Average Exercise Price
Outstanding at January 1, 2025			182,996			$	21.37
Exercised			(87,250	)			(18.41	)
Outstanding and exercisable at June 30, 2025			95,746			$	24.06

Options [Member]

Equity (Tables) [Line Items]

Schedule of Common Stock Issuable Upon Exercise of Options Outstanding

The following table summarizes the shares of the Company’s common stock issuable upon exercise of options outstanding at June 30, 2025:

Options Outstanding																Options Exercisable
Range of Exercise Price				Number Outstanding at June 30, 2025				Weighted Average Remaining Contractual Life (Years)				Weighted Average Exercise Price				Number Exercisable at June 30, 2025				Weighted Average Exercise Price
$	2.93 – 31.20				15,419				3.33			$	6.49				14,089			$	6.80
	48.75 – 123.00				19,317				1.65				78.87				19,317				78.87
	154.50 – 264.00				9,765				3.62				214.43				9,765				214.43
$	2.93 – 264.00				44,501				2.66			$	83.54				43,171			$	86.01

Warrants Outstanding [Member]

Equity (Tables) [Line Items]

Schedule of Common Stock Issuable Upon Exercise of Options Outstanding

The following table summarizes the shares of the Company’s common stock issuable upon exercise of warrants outstanding at June 30, 2025:

Warrants Outstanding																Warrants Exercisable
Range of Exercise Price				Number Outstanding at June 30, 2025				Weighted Average Remaining Contractual Life (Years)				Weighted Average Exercise Price				Number Exercisable at June 30, 2025				Weighted Average Exercise Price
$	7.50 – 37.50				86,593				3.93			$	8.01				86,593			$	8.01
	67.50				889				2.93				67.50				889				67.50
	187.50				8,264				1.81				187.50				8,264				187.50
$	7.50 – 187.50				95,746				3.74			$	24.06				95,746			$	24.06

X

- References

No definition available.

+ Details

Name:	avco_EquityTablesLineItems
Namespace Prefix:	avco_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the changes in outstanding nonvested shares.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_AwardTypeAxis=avco_OptionsOutstandingMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_AwardTypeAxis=avco_WarrantsOutstandingMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: